Vanguard Capital Management
ETON icon

Vanguard Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Vanguard Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4M Sell
976,570
-17,519
-2% -$514K ﹤0.01% 2130
2026
Q1 		$24.5M Buy
+994,089
New +$17.4M ﹤0.01% 2229

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Vanguard Capital Management's ETON Position: Q2 2026 in Review

Vanguard Capital Management reduced its Eton Pharmaceutcials (ETON) stake by 1.8% in Q2 2026, selling an estimated $514K and leaving 976,570 shares worth $35.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

Vanguard Capital Management first reported a position in ETON in Q1 2026 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Vanguard Capital Management held 976,570 shares of Eton Pharmaceutcials worth $35.4M as of Q2 2026.
  • Vanguard Capital Management sold 17,519 Eton Pharmaceutcials shares in Q2 2026, an estimated $514K.
  • Eton Pharmaceutcials made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2130 holding.
  • Vanguard Capital Management first reported a position in Eton Pharmaceutcials in Q1 2026 and has held it in 2 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.